Eisai
4523.T
#2013
Rank
$7.99 B
Marketcap
$28.35
Share price
0.12%
Change (1 day)
-43.20%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : $1.05 Billion USD

According to Eisai's latest financial reports the company's total debt is $1.05 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-03-31$0.94 B21.74%
2022-03-31$0.77 B-4.57%
2021-03-31$0.81 B-2.11%
2020-03-31$0.83 B-33.47%
2019-03-31$1.25 B-23.16%
2018-03-31$1.62 B-14.73%
2017-03-31$1.90 B5.41%
2016-03-31$1.81 B-7.89%
2015-03-31$1.96 B-18.14%
2014-03-31$2.40 B-27.86%
2013-03-31$3.33 B-20.07%
2012-03-31$4.16 B-8.79%
2011-03-31$4.56 B4.26%
2010-03-31$4.38 B2.84%
2009-03-31$4.26 B2.82%
2008-03-31$4.14 B206688.88%
2007-03-31$2 M-42.86%
2006-03-31$3.5 M-54.95%
2005-03-31$7.78 M324.71%
2004-03-31$1.83 M517.98%
2003-03-31$0.29 M-99.4%
2002-03-31$49.03 M-21.56%
2001-03-31$62.51 M-64.39%
2000-03-31$0.17 B